Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and ...

Pfizer also did well with oncology drugs such as Ibrance and Xtandi.

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...

MINNEAPOLIS — After more than 13 billion COVID vaccines given around the world, the largest studies to date point to the ...

GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District ...

In some people, COVID-19 vaccines can lead to heart complications called myocarditis and pericarditis. Myocarditis is the swelling, also called inflammation, of the heart muscle. Pericarditis is the ...

The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive ...

Pfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook, benefitting from its ...

Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines ...

Investors are always looking for stocks that are poised to beat at earnings season and The Hershey Company HSY may be one ...

DoorDash expects adjusted earnings before tax, interest, depreciation, and amortization between US$325-million and ...

Pfizer reiterated its annual revenue forecast of $8 billion from the sale of COVID-19 shot Comirnaty and anti-viral treatment ...